Daxin Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2014.
2014 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Daxin Pharmaceuticals Private Limited

Daxin Pharmaceuticals Private Limited, a active private limited company, was established on 06 February 2014 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100DL2014PTC264559. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹9.84 Cr.

It upholds a compliant status. Employing 78 professional, Its leadership includes Sheela Jha (Director), Nikhil Kumar Jha (Director). Past directors included Anand Kumar Jha. It holds ₹30.55 Cr open charges and ₹1.95 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No-204, 205, 2Nd Floor, Apra Dwarka Plaza-I, Plot No-21, Sector-10, Dwarka, New Delhi, Delhi, 110075.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100DL2014PTC264559

  • Registration Number

    264559

  • Incorporation Date

    06 February 2014

  • Authorized Capital

    ₹10.00 Cr

  • Paid-Up Capital

    ₹9.84 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 9.84 Cr
  • Company Age 12 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 30.55 Cr
  • Satisfied Charges ₹ 1.95 Cr
  • Revenue Growth **** 22.14%
  • Profit Growth **** 1388.04%
  • Ebitda **** 51.54%
  • Net Worth 14.68%
  • Total Assets **** 10.44%
Company report

Daxin Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Daxin Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Daxin Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Sheela Jha Director 06 Feb 2014 Current
Nikhil Kumar Jha Director 16 Feb 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 16 Feb 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Daxin Pharmaceuticals.

Daxin Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 22.14% increase. The company also saw a substantial improvement in profitability, with a 1388.04% increase in profit. The company's net worth Soared by an impressive increase of 14.68%.

Daxin Pharmaceuticals revenue growth over time
Daxin Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 22.14%
*******
*******
*******
*******
Revenue from Operations
*******
 22.12%
*******
*******
*******
*******
Total Assets
*******
 10.44%
*******
*******
*******
*******
Profit or Loss
*******
 1388.04%
*******
*******
*******
*******
Net Worth
*******
 14.68%
*******
*******
*******
*******
EBITDA
*******
 51.54%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Daxin Pharmaceuticals?

In 2024, Daxin Pharmaceuticals had a promoter holding of 56.73% and a public holding of 43.27%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹305,497,000.00

Satisfied Charges

₹19,500,000.00

Charges Breakdown by Lending Institutions
  • Others : 30.55 Cr
Latest Charge Details
Date Lender Amount Status
20 Apr 2024 Others ₹3.30 M Open
25 Nov 2021 Others ₹1.05 Cr Open
20 Nov 2020 Others ₹29.17 Cr Open
30 May 2015 Others ₹1.95 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Daxin Pharmaceuticals?

Daxin Pharmaceuticals has a workforce of 78 employees as of Mar 24, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Daxin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daxin Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Daxin Pharmaceuticals
Recent Activity within the Organization
  • Charges

    A charge with Others of Rs. 29.17 Cr registered on 20 Nov 2020 with Charge ID 100402828 was modified on 03 Jun 2025. was recorded as a recent event.

  • Annual General Meeting

    The activity Daxin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 0.33 Cr with Charge ID 100913441 was registered on 20 Apr 2024. was documented.

  • Balance Sheet

    The activity Daxin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.

  • Charges

    The activity A charge registered on 30 May 2015 via Charge ID 10578019 with Others was fully satisfied on 04 Jan 2024. was completed.

  • Charges

    The activity A charge with Others amounted to Rs. 1.05 Cr with Charge ID 100504861 was registered on 25 Nov 2021. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Daxin Pharmaceuticals Private Limited?

The CIN of Daxin Pharmaceuticals Private Limited is U24100DL2014PTC264559.

Where is Daxin Pharmaceuticals Private Limited headquartered?

Daxin Pharmaceuticals Private Limited is headquartered at Office No-204, 205, 2Nd Floor, Apra Dwarka Plaza-I, Plot No-21, Sector-10, Dwarka, New Delhi, Delhi, 110075.

When was Daxin Pharmaceuticals Private Limited incorporated?

Daxin Pharmaceuticals Private Limited was incorporated on 06 February 2014.

Who are the current directors of Daxin Pharmaceuticals Private Limited?

The current directors of Daxin Pharmaceuticals Private Limited are

What is the primary industry of Daxin Pharmaceuticals Private Limited?

The primary industry of Daxin Pharmaceuticals Private Limited is Manufacturing.

Is Daxin Pharmaceuticals Private Limited a listed company?

Daxin Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Daxin Pharmaceuticals Private Limited?

The authorized capital of Daxin Pharmaceuticals Private Limited is ₹10.00 Cr, and the paid-up capital is ₹9.84 Cr.

What is the compliance status of Daxin Pharmaceuticals Private Limited?

The compliance status of Daxin Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available